OpenVSafe by OpenVAERS
Search V-safe

GME-71897-56192

1 vaccination 1 coded response 2 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
201 / VA
Registered
2021-04-16
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-16
    Registered in v-safe
  2. 2021-04-16
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-16
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2022-04-16
    Survey response — 12 months, dose 1
    MedDRA: Chest pain, Cough, Fatigue, Pain, Respiratory tract congestion, Sinusitis — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization
    Free text: Fatigue, soreness, sinus infection, cough, congestion, chest pain
    MedDRA releases: 2024-11 · check-in free text available
  5. 2022-04-16
    Report sent to call center — 12 months, dose 1
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Hospitalization · 1 call case(s)
  6. 2022-04-20
    Call successful
    Not applicable - Accidental Reporting

Vaccinations

DoseDateManufacturerCo-administered
12021-04-16Pfizer-BioNTech

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 11 — 12 months, dose 1

2022-04-16

Symptoms: Fatigue, soreness, sinus infection, cough, congestion, chest pain

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChest pain · · ✓
SDCough · · ✓
SDFatigue · · ✓
SDPain · · ✓
SDRespiratory tract congestion · · ✓
SDSinusitis · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release